← SynDRA
JX-401
SynDRA canonical compound SYN0086783 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | P38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- JX401
- RefChem:792610
- JX 401
- TBU7UTV30Q
- UNII-TBU7UTV30Q
- C21H25NO2S
- Oprea1_085278
- Oprea1_772012
- SCHEMBL159145
- orb1704447
- CHEBI:92098
- HMS3229J09
- HMS3261N05
- HMS3269J21
- HMS3413P05
- HMS3677P05
- ZNA08734
- Tox21_500542
- EX-A14190
- HB1298
- MFCD02038777
- STK217901
- AKOS000646768
- CCG-221846
- LP00542
- SDCCGSBI-0207175.P002
- NCGC00167816-01
- NCGC00167816-02
- NCGC00261227-01
- p38 MAP Kinase Inhibitor VI, JX401
- MS-32626
- ST079029
- DB-388934
- HY-108346
- CS-0028424
- T22885
- SR-01000453315
- SR-01000453315-1
- 2-methoxy-4-methylthiophenyl 4-benzylpiperidyl ketone
Look up JX-401 in the interactive SynDRA portal →